C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $597,000 in DaVita Inc. (NYSE:DVA)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in DaVita Inc. (NYSE:DVA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,994 shares of the company’s stock, valued at approximately $597,000.

Several other hedge funds and other institutional investors have also made changes to their positions in DVA. Franklin Resources Inc. lifted its holdings in DaVita by 134.6% in the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after acquiring an additional 31,502 shares during the last quarter. FMR LLC increased its position in shares of DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the period. Atom Investors LP acquired a new position in DaVita during the third quarter worth about $4,094,000. Assenagon Asset Management S.A. raised its holdings in shares of DaVita by 201.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after purchasing an additional 49,885 shares in the last quarter. Finally, Neo Ivy Capital Management bought a new position in shares of DaVita in the third quarter valued at $726,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analysts Set New Price Targets

Separately, Barclays upped their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, DaVita presently has a consensus rating of “Hold” and an average price target of $161.80.

DaVita Price Performance

Shares of NYSE:DVA opened at $177.45 on Friday. DaVita Inc. has a 1-year low of $118.56 and a 1-year high of $179.60. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The business’s 50 day moving average is $161.47 and its 200-day moving average is $157.25. The firm has a market capitalization of $14.55 billion, a PE ratio of 19.14, a PEG ratio of 0.84 and a beta of 0.94.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 6.53% and a return on equity of 88.18%. Sell-side analysts predict that DaVita Inc. will post 9.71 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.